Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Erck Stanley C Create: Alert

All | News | Filings
Date FiledTypeDescription
12/16/2022 4 Erck Stanley C (President and CEO) has filed a Form 4 on NOVAVAX INC
Txns: Paid exercise price by delivering 2,320 shares @ $17.23, valued at $40k
Exercised 6,966 restricted stock units @ $0
09/28/2022 4 Erck Stanley C (President and CEO) has filed a Form 4 on NOVAVAX INC
Txns: Paid exercise price by delivering 2,180 shares @ $18.87, valued at $41.1k
Exercised 6,546 restricted stock units @ $0
07/08/2022 4 Erck Stanley C (Director) has filed a Form 4 on MAXCYTE, INC.
Txns: Granted 26,900 options to buy @ $4.82, valued at $129.7k
03/14/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/16/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/28/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/11/2021 4 Erck Stanley C (Director) has filed a Form 4 on MAXCYTE, INC.
Txns: Granted 10,000 options to buy @ $16.63, valued at $166.3k
07/06/2021 4 Erck Stanley C (President and CEO) has filed a Form 4 on NOVAVAX INC
Txns: Sold 2,046 shares @ $209.2027, valued at $428k
Sold 6,105 shares @ $210.0229, valued at $1.3M
Sold 4,117 shares @ $211.0679, valued at $869k
Sold 6,419 shares @ $212.1527, valued at $1.4M
Sold 12,703 shares @ $213.071, valued at $2.7M
Sold 12,917 shares @ $214.127, valued at $2.8M
Sold 6,984 shares @ $214.9681, valued at $1.5M
Sold 1,329 shares @ $215.6983, valued at $286.7k
Sold 1,970 shares @ $210.2299, valued at $414.2k
Sold 4,242 shares @ $211.2084, valued at $895.9k
Sold 7,616 shares @ $212.2878, valued at $1.6M
12/16/2020 4 Erck Stanley C (President and CEO) has filed a Form 4 on NOVAVAX INC
Txns: Granted 41,700 options to buy @ $129.7, valued at $5.4M
Granted 20,900 restricted stock units @ $0
11/18/2020 4 Erck Stanley C (President and CEO) has filed a Form 4 on NOVAVAX INC
Txns: Sold 5,766 shares @ $87.2042, valued at $502.8k
Sold 8,306 shares @ $88.36, valued at $733.9k
Sold 11,234 shares @ $89.2566, valued at $1M
Sold 4,598 shares @ $90.6128, valued at $416.6k
Sold 17,503 shares @ $92.9721, valued at $1.6M
Sold 4,909 shares @ $93.5613, valued at $459.3k
Exercised 42,499 options to buy @ $39.8, valued at $1.7M
Exercised 9,818 options to buy @ $25.6, valued at $251.3k
10/01/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/30/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/29/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/26/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/29/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/10/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/30/2019 4 Erck Stanley C (President and CEO) has filed a Form 4 on NOVAVAX INC
Txns: Granted 100,000 options to buy @ $5.95, valued at $595k
Granted 100,000 rights @ $5.95, valued at $595k
Granted 19,638 restricted stock units @ $0
03/12/2019 4 Erck Stanley C (President and CEO) has filed a Form 4 on NOVAVAX INC
Txns: Granted 607,248 restricted stock units @ $0
12/14/2018 4 Erck Stanley C (President and CEO) has filed a Form 4 on NOVAVAX INC
Txns: Granted 1,970,000 options to buy @ $2.3, valued at $4.5M
11/30/2018 4 Erck Stanley C (Director) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC
Txns: Exercised 8,333 options to buy @ $1.49, valued at $12.4k
06/22/2018 4 Erck Stanley C (Director) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC
Txns: Granted 30,000 options to buy @ $6.09, valued at $182.7k
05/15/2018 4 Erck Stanley C (President and CEO) has filed a Form 4 on NOVAVAX INC
Txns: Bought 100,000 shares @ $1.6462, valued at $164.6k
12/19/2017 4 Erck Stanley C (President and CEO) has filed a Form 4 on NOVAVAX INC
Txns: Granted 1,650,000 options to buy @ $1.38, valued at $2.3M
11/13/2017 4 Erck Stanley C (President and CEO) has filed a Form 4 on NOVAVAX INC
Txns: Bought 100,000 shares @ $1.1305, valued at $113.1k
05/25/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
05/11/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
11/16/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
05/25/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
04/01/2016 4 Erck Stanley C (President and CEO) has filed a Form 4 on NOVAVAX INC
Txns: Sold 198,009 shares @ $5.1917, valued at $1M
Sold 226,769 shares @ $5.1842, valued at $1.2M
Exercised 198,009 options to buy @ $1.28, valued at $253.5k
Exercised 201,991 options to buy @ $1.28, valued at $258.5k
06/03/2013 4 Erck Stanley C (Director) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC
Txns: Granted 15,000 options to buy @ $1.71, valued at $25.7k
03/06/2013 4 Erck Stanley C (President and CEO) has filed a Form 4 on NOVAVAX INC
Txns: Granted 900,000 options to buy @ $1.83, valued at $1.6M
05/25/2012 4 Erck Stanley C (Director) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC
Txns: Granted 15,000 options to buy @ $3.32, valued at $49.8k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy